Sign in
4

Changes in Ownership

Vistagen Therapeutics, Inc. Filed Acc 0001415889-24-023146

Options or other derivatives

  • Director acquired 14,100 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Cunningham Ann Michelle Director 2024-09-06 Grant or award · Stock Option (Right to Buy) +14,100 14,100 D
Loading xslF345X05/form4-09102024_050905.xml…